Phospho-SRC (S75) Antibody

What is Phospho-SRC (S75) Antibody and what does it specifically detect?

Phospho-SRC (S75) Antibody is a rabbit polyclonal antibody that specifically detects endogenous levels of SRC protein only when phosphorylated at serine 75. The antibody is designed to recognize the phosphorylated epitope within the sequence context around this residue. Most commercially available antibodies are generated using synthetic phosphopeptides derived from human c-Src around the phosphorylation site of Serine 75, with immunogens typically containing sequences such as V-T-S(p)-P-Q . This specificity makes it a valuable tool for studying the regulation of SRC activity through serine phosphorylation mechanisms.

What are the primary research applications for Phospho-SRC (S75) Antibody?

The primary research applications include:

• Western Blot (WB): For detecting denatured Phospho-SRC (S75) in protein samples

• Immunohistochemistry (IHC): For visualizing Phospho-SRC (S75) in tissue sections

• Immunofluorescence/Immunocytochemistry (IF/ICC): For cellular localization studies

• ELISA: For quantitative detection of Phospho-SRC (S75)

Recommended dilutions vary by application:

• WB: 1/500-1/2000

• IHC: 1/100-1/300

• ELISA: 1/5000

What species reactivity does Phospho-SRC (S75) Antibody typically exhibit?

Most commercially available Phospho-SRC (S75) antibodies exhibit confirmed reactivity against human, mouse, and rat samples . Some antibodies are predicted to cross-react with additional species including pig, bovine, sheep, rabbit, dog, chicken, and xenopus samples, although these predictions require experimental validation . When selecting an antibody for your research, it's important to verify the validated species reactivity in the specific product documentation, especially for non-mammalian model organisms.

How should I validate Phospho-SRC (S75) Antibody specificity in my experiments?

Validation of Phospho-SRC (S75) Antibody specificity should include:

• Peptide competition assay: Pre-incubate the antibody with the phosphorylated peptide antigen. In properly validated antibodies, this completely blocks signal in Western blot analysis, as demonstrated in validation data from COLO205 tissue extracts .

• Phosphatase treatment: Treat half of your sample with lambda phosphatase to remove phosphate groups. The signal should significantly decrease or disappear in the phosphatase-treated sample.

• S75A mutant controls: Include Src(S75A) mutant samples as negative controls when possible, as they cannot be phosphorylated at this site.

• siRNA/shRNA knockdown: Reducing total SRC expression should proportionally reduce phospho-specific signal.

• Cdk5 inhibition: As Cdk5 is known to phosphorylate SRC at S75, treatment with Cdk5 inhibitors should reduce phospho-S75 signal, providing functional validation .

What are the recommended protocols for sample preparation when detecting Phospho-SRC (S75)?

For optimal detection of Phospho-SRC (S75):

• Lysis buffer selection: Use RIPA buffer supplemented with both phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) and protease inhibitors.

• Temperature considerations: Keep samples cold throughout preparation to preserve phosphorylation status.

• Timing: Process samples quickly to minimize phosphatase activity.

• Quantification: Determine protein concentration using Bradford or BCA assay before proceeding to immunoblotting.

• Sample handling: For Western blot, avoid repeated freeze-thaw cycles of samples.

• Fixation for IHC/ICC: For immunohistochemistry or immunocytochemistry, use 4% paraformaldehyde fixation rather than methanol, as the latter can affect phosphoepitope preservation.

• Blocking: Use 5% BSA rather than milk for blocking and antibody dilution, as milk contains phosphoproteins that may interfere with phospho-specific antibody binding .

How can I properly normalize phospho-SRC (S75) signal to total SRC?

For accurate interpretation of phosphorylation levels:

• Dual detection: Run duplicate gels - one probed with phospho-specific antibody and one with total SRC antibody.

• Stripping and reprobing: If using a single membrane, completely strip and verify stripping efficiency before reprobing for total SRC.

• Normalization calculation: Calculate the ratio of phospho-SRC to total SRC signal by densitometry, using software such as ImageJ.

• Loading control: Additionally normalize to a housekeeping protein (β-actin, GAPDH) to account for loading variations.

• Technical considerations: Ensure signal is in the linear range of detection for accurate quantification.

• Molecular weight confirmation: Verify that both phospho-SRC and total SRC signals appear at the expected molecular weight of approximately 60 kDa .

What is the biological significance of SRC phosphorylation at Serine 75?

SRC phosphorylation at Serine 75 plays a critical regulatory role:

• Ubiquitin-dependent degradation: Cdk5-dependent phosphorylation of SRC at S75 promotes the ubiquitin-dependent degradation of SRC, restricting the availability of active SRC .

• Activity regulation: Preventing S75 phosphorylation (via S75A mutation or Cdk5 inhibition) increases SRC(Y419) phosphorylation and kinase activity, resulting in SRC-dependent cytoskeletal changes .

• Protein stability: In transfected cells, ubiquitinylation of SRC(S75A) is approximately 35% that of wild-type SRC-V5, and its half-life is approximately 2.5-fold greater .

• Enzymatic activity correlation: The ratio of kinase activity to Y419 phosphorylation remains constant regardless of S75 phosphorylation status, indicating that S75 phosphorylation affects the amount of active SRC rather than altering the specific activity of each SRC molecule .

• Selective targeting: Importantly, S75 phosphorylation appears to be associated only with active SRC, similar to ubiquitinylation, which affects active SRC(pY419) exclusively .

How does Cdk5-dependent phosphorylation of SRC at S75 interact with other SRC regulatory mechanisms?

SRC regulation involves multiple interacting mechanisms:

• Dual regulation system: SRC activity is controlled through two main mechanisms:

  • Csk-dependent phosphorylation of SRC(Y530)

  • Cullin-5-dependent ubiquitinylation leading to proteasomal degradation

• S75 phosphorylation and degradation: Cdk5-dependent phosphorylation of SRC(S75) promotes ubiquitin-dependent degradation specifically of active SRC, providing an additional layer of regulation .

• Cross-talk with Y419 phosphorylation: Preventing S75 phosphorylation increases Y419 phosphorylation, a marker of SRC activation, indicating interplay between these different phosphorylation sites .

• Selective degradation: Unlike Y530 phosphorylation which inactivates SRC, S75 phosphorylation appears to target active SRC for degradation, suggesting a mechanism for terminating SRC signaling rather than preventing activation .

• Half-life regulation: Cdk5 suppression leads to decreased ubiquitinylation of endogenous SRC and increased SRC stability, with experimental data showing approximately 2.5-fold increase in half-life .

What are the key downstream effects of altered SRC(S75) phosphorylation?

Altered SRC(S75) phosphorylation has several downstream consequences:

• Cytoskeletal changes: Increased SRC activity due to reduced S75 phosphorylation results in SRC-dependent cytoskeletal rearrangements .

• Cell adhesion and migration: As SRC is a critical regulator of cytoskeletal contraction, cell adhesion, and migration, changes in S75 phosphorylation can impact these processes .

• Signal duration control: S75 phosphorylation may serve as a mechanism to limit the duration of SRC signaling by targeting active SRC for degradation, thus affecting the temporal dynamics of downstream pathways .

• Pathway specificity: The selective degradation of active SRC through S75 phosphorylation may allow for specific regulation of certain SRC-dependent pathways without affecting others.

• Potential cancer implications: Given that SRC dysregulation is associated with various cancers, alterations in S75 phosphorylation could contribute to pathological SRC activity in disease states .

How can I use Phospho-SRC (S75) Antibody to study the kinetics of SRC regulation?

For kinetic studies of SRC regulation:

• Pulse-chase experiments: Use 35S methionine labeling followed by immunoprecipitation with Phospho-SRC (S75) antibody to track protein turnover rates. Research has shown that mutation of S75 to S75A results in approximately 2.5-fold increase in SRC half-life .

• Time-course treatments: Design experiments with Cdk5 inhibitors or activators and collect samples at multiple time points to track changes in S75 phosphorylation. Normalize to total SRC.

• Protein synthesis inhibition: Use cycloheximide to block new protein synthesis and track degradation rates of phosphorylated versus non-phosphorylated SRC.

• Ubiquitinylation assays: Combine with ubiquitin analysis to correlate S75 phosphorylation with ubiquitinylation kinetics. Published data indicates ubiquitinylation of Src(S75A) is about 35% that of wild-type Src-V5 .

• Proteasome inhibition: Use MG132 to block proteasomal degradation and assess accumulation of phospho-S75 SRC versus total SRC.

• Quantitative phosphoproteomics: For global analysis, combine with mass spectrometry-based approaches to monitor multiple phosphorylation sites simultaneously.

What are the technical challenges in detecting low levels of Phospho-SRC (S75) in primary cells or tissues?

Researchers face several challenges when detecting low levels of Phospho-SRC (S75):

• Signal amplification strategies:

  • Use enhanced chemiluminescence (ECL) substrates with extended sensitivity

  • Consider tyramide signal amplification for IHC/ICC applications

  • Explore proximity ligation assay (PLA) for detecting low-abundance phosphoproteins

• Enrichment approaches:

  • Immunoprecipitate total SRC before probing for phospho-S75

  • Use phosphoprotein enrichment columns prior to analysis

  • Concentrate samples through TCA precipitation before Western blotting

• Reducing background issues:

  • Optimize blocking conditions (5% BSA typically works better than milk for phospho-epitopes)

  • Increase washing stringency with higher detergent concentrations

  • Use highly purified primary antibody preparations

• Preservation of phosphorylation:

  • Ensure rapid tissue collection and flash-freezing

  • Include phosphatase inhibitor cocktails in all buffers

  • Maintain samples at cold temperatures throughout processing

• Specificity confirmation:

  • Always include a peptide competition control

  • Use genetic models (S75A mutants) as negative controls when possible

  • Consider inhibitor treatments (Cdk5 inhibitors) as functional controls

How can I investigate the cross-talk between S75 phosphorylation and other post-translational modifications of SRC?

To investigate post-translational modification cross-talk:

• Sequential immunoprecipitation: First immunoprecipitate with one modification-specific antibody, then probe the immunoprecipitate with antibodies against other modifications.

• Phosphorylation site mutants: Generate combinations of phospho-site mutants (e.g., S75A/Y419F, S75A/Y530F) to study interdependence of different sites. Research has shown that S75A mutation increases Y419 phosphorylation, indicating cross-talk between these sites .

• Inhibitor combinations: Use specific kinase inhibitors in combination (e.g., Cdk5 inhibitors plus SRC inhibitors) to dissect signaling hierarchies.

• Mass spectrometry analysis: Perform LC-MS/MS analysis of immunoprecipitated SRC to identify all post-translational modifications simultaneously and their stoichiometric relationships.

• Functional correlation: Correlate multiple modifications with specific SRC functions using activity assays. Research indicates that the ratio of kinase activity to Y419 phosphorylation remains consistent regardless of S75 phosphorylation status .

• Subcellular fractionation: Determine if different modified forms of SRC localize to distinct cellular compartments.

• Computational modeling: Integrate experimental data into mathematical models to predict how modifications interact to regulate SRC activity and stability.

How should I interpret changes in Phospho-SRC (S75) levels when total SRC also changes?

Interpreting phosphorylation changes requires careful consideration:

• Normalization approaches:

  • Always calculate the ratio of phospho-SRC to total SRC

  • Consider additional normalization to housekeeping proteins

  • In cases of dramatic total SRC changes, present both normalized and raw data for transparency

• Mechanistic considerations:

  • Increased phospho-SRC/total SRC ratio suggests enhanced Cdk5 activity or decreased phosphatase activity

  • Decreased ratio with increased total SRC may indicate inhibition of the Cdk5-dependent degradation pathway

  • Consider that S75 phosphorylation may be selectively targeting active SRC

• Time-course analysis:

  • Short-term changes may reflect altered kinase/phosphatase balance

  • Longer-term changes could indicate altered synthesis/degradation equilibrium

  • Research shows that preventing S75 phosphorylation increases SRC half-life by approximately 2.5-fold

• Technical validation:

  • Verify antibody specificity under your experimental conditions

  • Ensure signal is within linear range of detection

  • Consider absolute quantification methods (e.g., using phosphopeptide standards)

What are common pitfalls in Phospho-SRC (S75) detection and how can they be avoided?

Common pitfalls and their solutions include:

• Loss of phosphorylation during sample preparation:

  • Always include fresh phosphatase inhibitors in lysis buffers

  • Process samples rapidly and keep them cold

  • Avoid extended storage of protein samples before analysis

• Non-specific antibody binding:

  • Include proper negative controls (peptide competition, S75A mutants)

  • Optimize antibody concentration through titration

  • Verify specificity in your specific research context/model

• Inconsistent results between replicates:

  • Standardize cell culture conditions/tissue collection procedures

  • Prepare master mixes of reagents to reduce pipetting variability

  • Control for cell density, passage number, and treatment timing

• Difficulty detecting signal in tissue samples:

  • Consider antigen retrieval methods for IHC

  • Optimize tissue fixation protocols for phosphoepitope preservation

  • Use signal amplification methods for low abundance targets

• Cross-reactivity with related proteins:

  • Confirm specificity through knockout/knockdown validation

  • Use orthogonal detection methods to verify findings

  • Consider the possibility of related SRC family kinases being detected

How can I resolve contradictory results between different experimental approaches when studying SRC(S75) phosphorylation?

Resolving contradictory results requires systematic troubleshooting:

• Methodological differences:

  • Compare detection methods (WB vs. IHC vs. ELISA) and their limitations

  • Consider that different antibodies may recognize slightly different epitopes

  • Evaluate fixation/extraction protocols that may affect epitope accessibility

• Contextual variability:

  • Cell-type specific effects may influence SRC regulation

  • Growth conditions can affect basal phosphorylation levels

  • Cell density and contact inhibition may impact SRC signaling

• Temporal dynamics:

  • Phosphorylation is a dynamic process—ensure consistent timing in experiments

  • Consider kinetics of phosphorylation/dephosphorylation and degradation

  • Research shows Cdk5-dependent phosphorylation affects SRC stability and half-life

• Validation through genetic approaches:

  • Use CRISPR/Cas9 to generate S75A knock-in models

  • Employ multiple siRNA/shRNA constructs to confirm Cdk5 dependency

  • Validate with rescue experiments using wild-type vs. mutant constructs

• Integration of multiple techniques:

  • Combine biochemical assays with imaging approaches

  • Supplement antibody-based detection with mass spectrometry

  • Correlate phosphorylation with functional readouts (kinase activity, cytoskeletal changes)

How might Phospho-SRC (S75) analysis contribute to understanding disease mechanisms?

Phospho-SRC (S75) analysis has significant potential for disease research:

• Cancer biology: SRC dysregulation is implicated in various cancers, including colon, breast, and prostate cancer. Analysis of S75 phosphorylation could reveal altered degradation mechanisms contributing to elevated SRC activity in tumors .

• Neurological disorders: Given Cdk5's prominent role in neuronal function and dysregulation in neurodegenerative diseases, the Cdk5-SRC axis through S75 phosphorylation might be relevant in conditions like Alzheimer's disease.

• Inflammatory conditions: SRC plays key roles in immune cell signaling and inflammation. Altered S75 phosphorylation could affect inflammatory processes through modulation of SRC activity duration.

• Drug resistance mechanisms: Changes in SRC degradation through altered S75 phosphorylation might contribute to resistance against SRC inhibitors in cancer treatment.

• Biomarker development: The ratio of phospho-S75 to total SRC could potentially serve as a biomarker for Cdk5 activity or SRC stability in disease states.

• Therapeutic targeting: Understanding this regulatory mechanism might reveal new approaches to modulate SRC activity indirectly through Cdk5 or the ubiquitin-proteasome system.

What novel methodologies might enhance the study of SRC(S75) phosphorylation dynamics?

Emerging technologies offer new opportunities:

• Live-cell biosensors: Development of FRET-based sensors that can detect S75 phosphorylation in real-time in living cells.

• Single-cell phosphoproteomics: Analysis of S75 phosphorylation at the single-cell level to reveal cell-to-cell variability in SRC regulation.

• CRISPR base editing: Precise mutation of endogenous S75 to alanine or glutamic acid to study phosphorylation effects without overexpression artifacts.

• Optogenetic approaches: Light-controlled activation of Cdk5 to study temporal aspects of S75 phosphorylation with high precision.

• Super-resolution microscopy: Nanoscale visualization of phospho-S75 SRC localization relative to degradation machinery.

• Targeted degradation technologies: Use of PROTACs (proteolysis targeting chimeras) to selectively degrade phospho-S75 SRC for functional studies.

• Mass spectrometry imaging: Spatial mapping of phospho-S75 SRC distribution in tissues for correlation with pathological features.

What are promising research questions regarding the tissue-specific regulation of SRC through S75 phosphorylation?

Several tissue-specific research questions warrant investigation:

• Neuronal regulation: Given that neurons and platelets express 5-200 fold higher levels of SRC than most other tissues , how does S75 phosphorylation contribute to neuronal SRC regulation?

• Cell-type specific consequences: Does S75 phosphorylation have different functional outcomes in epithelial cells versus immune cells versus neurons?

• Developmental regulation: How does the Cdk5-SRC axis through S75 phosphorylation change during embryonic development and tissue differentiation?

• Stimulus-specific responses: Are there tissue-specific stimuli that preferentially induce or inhibit S75 phosphorylation?

• Isoform-specific effects: Do alternative SRC isoforms or related SRC family kinases show differential regulation through analogous serine phosphorylation?

• Microenvironmental influence: How do tissue-specific extracellular matrix components or cell-cell interactions affect S75 phosphorylation?

• Pathological alterations: Are there tissue-specific changes in S75 phosphorylation in different disease states that correlate with SRC dysregulation?

How can computational modeling enhance our understanding of SRC regulation through S75 phosphorylation?

Computational approaches offer valuable insights:

What collaborative approaches between different research disciplines could advance understanding of SRC(S75) phosphorylation?

Interdisciplinary collaborations offer rich opportunities:

• Biochemistry and structural biology: Determine how S75 phosphorylation affects SRC conformation and interaction with the ubiquitin machinery.

• Cell biology and biophysics: Combine live-cell imaging with biophysical techniques to measure how S75 phosphorylation affects SRC diffusion, clustering, and membrane association.

• Developmental biology and cancer research: Compare S75 phosphorylation in embryonic development versus tumor progression to identify conserved and divergent regulatory mechanisms.

• Immunology and neuroscience: Examine potential similarities and differences in S75 regulation between immune cells and neurons, both of which rely heavily on SRC signaling.

• Pharmacology and chemical biology: Develop small molecules or peptides that specifically interfere with S75 phosphorylation to create new research tools and potential therapeutic leads.

• Bioengineering and synthetic biology: Design synthetic circuits incorporating the Cdk5-SRC module to create cells with customized signaling properties.

• Clinical research and molecular pathology: Correlate S75 phosphorylation levels in patient samples with disease progression and treatment responses.

How does the Phospho-SRC (S75) regulatory mechanism compare with similar phosphorylation-dependent protein degradation systems?

Comparative analysis reveals important principles:

• Common mechanisms: Like other phosphodegrons (phosphorylation-dependent degradation signals), S75 phosphorylation appears to create or enhance recognition sites for ubiquitin ligase complexes, as demonstrated by the approximately 65% reduction in ubiquitinylation of Src(S75A) compared to wild-type .

• Specificity determinants: Unlike some phosphodegrons that affect all protein molecules, S75 phosphorylation specifically targets active SRC, similar to how phosphorylation of c-Myc at T58 selectively targets a subset of the protein pool.

• Kinase-specific regulation: Cdk5's role in SRC regulation through S75 phosphorylation parallels other cell cycle kinases that control protein stability, though Cdk5 functions primarily in post-mitotic contexts.

• Integration with other modifications: The interplay between S75 phosphorylation and Y419 phosphorylation resembles hierarchical phosphorylation seen in other systems like β-catenin regulation.

• Evolutionary conservation: Comparative analysis across species could reveal whether this regulatory mechanism is evolutionarily conserved or represents a specialized adaptation in certain organisms.

• Therapeutic implications: Understanding this mechanism in comparison with other phosphorylation-dependent degradation systems may reveal common vulnerabilities that could be exploited therapeutically.